Interferon-γ selectively promotes survival of alveolar progenitor cells in a human lung organoid model

Read full text
Authors: Antonella F M Dost, Katarína Balážová, Carla Pou Casellas, Lisanne M. van Rooijen, Wisse Epskamp, Gijs J F van Son, Willine J. van de Wetering, Carmen Lopez-Iglesias, Harry Begthel, Peter J Peters, Niels Smakman, Johan H. van Es
+1 more Hans Clevers
Cited by: 4
References: 69

Abstract

Disease of the lung alveoli is frequently associated with acute or chronic inflammation. At present, there are no effective therapies to support regeneration of the alveolar epithelium, and ongoing inflammation adds an additional layer of complexity to many lung diseases. Here, we describe a primary adult human organoid model for investigating how inflammation shapes alveolar regeneration. Unlike previous models, this system supports long-term expansion of newly identified human-specific alveolar progenitor cells and serum-free differentiation into alveolar type 1 (AT1)-like cells. Using this platform, we find that interferon-gamma (IFN-γ) exerts cytotoxic effects on mature AT1-like cells while promoting survival of alveolar progenitor cells mediated by BIRC3. This unexpected selective positive effect of IFN-γ on alveolar progenitors underscores the need for nuanced and context-dependent evaluation of the influence of pro-inflammatory cytokines on alveolar regeneration. Our organoid model provides a reductionist platform for mechanistic studies and discovery of strategies to enhance alveolar regeneration.

Fields of Study & Subjects

Neonatal Respiratory Health Research Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Inhalation and Respiratory Drug Delivery

Publication details

Journal / source
The EMBO Journal
Publisher
Springer Science and Business Media LLC
Volume
45
Issue
10
Pages
3364–3395
Publication date
16 April 2026
Language
EN